Become a Patient

June 12, 2008

Asthma Inhalers Undergo Federally Mandated Change

Millions of asthma patients are facing a federally mandated change by the end of the year in the inhalers they use.  For many, there is concern and confusion over the change and how it will affect them.  The medicine in quick-relief asthma inhalers is staying the same, but the chemical used to “propel” the medicine is changing.

Beginning January 1, 2009, chlorofluorocarbons, or CFCs, will be eliminated as propellants for the asthma medication albuterol, because CFCs damage Earth’s protective ozone layer.  The propellants are being replaced with several new kinds of inhalers that are more environment-friendly.  Most controller medications that have recently come on the market contain environmentally safe propellants, but now patients are having to switch their rescue medication inhalers.

“With these new rescue inhalers on the market, it is even more of a challenge to teach patients to use their inhalers correctly,” said Melanie Gleason, Physician Assistant at National Jewish.  “Fortunately, many of the new inhalers have advantages that make them more effective once people learn how to operate them.”

The different kinds of inhalers, using hydrofluoroalkane (HFA) as a propellant, require different techniques.   If people don’t use their inhalers properly, less medication reaches the airways where it is needed.  As a result, asthma patients can continue to suffer asthma symptoms and attacks even though they are using their inhalers.

Some of the changes that patients can expect with the HFA inhalers include: spray pressure, taste, priming and cleaning techniques, and cost.  Below are some links to help make your transition to HFA inhalers easier.

The National Jewish Web site has specific instructions for properly using several of the most common inhalers.  Go to “Treatments and Medications.”  There is also specific information on cleaning and priming different HFA inhalers.  Go to “What’s New with Metered Dose Inhalers?

The Asthma and Allergy Foundation of America has set up a Web site to provide information to patients and answer frequently asked questions about the transition from CFC inhalers to HFA inhalers.  Click here.

Also, make sure you speak with your doctor about your overall asthma management plan and find out which treatments are right for you.

 

For More Information, Contact:

Adam Dormuth
303-398-1082
dormutha@njc.org

© Copyright 2008 National Jewish Health

National Jewish Health in the News

Exploring Personalized Medicine (Audio)
-- Colorado Public Radio

Teaming up to Fight Food Allergies
-- 9News

When the Workplace Makes You Sick
-- New York Times

Law Lightens Fear of Genetic Discrimination
-- Denver Post

Research Uncovers Clues to Lymphoma
-- U.S. News and World Report

Who's a Good (Germy) Boy?
-- Newsweek

Asthma and Allergies Could Start in the Womb
-- ABC News

New Directions Online

Read the latest issue of New Directions, a publication for friends of National Jewish Health. It includes news briefs, donor profiles, patient profiles and an ask the expert section.

Search Press Releases

  Go

Browse by Year 
2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996 

Media Contacts

William Allstetter 
Tel: (303) 398-1002 
Pager: (303) 281-1653 
E-mail: allstetterw@njc.org

Adam Dormuth
Tel: (303) 398-1082
Pager: (303) 851-0358
E-mail: dormutha@njc.org